Vermont § 9472 - Pharmacy benefit managers; required practices with respect to health insurers and covered persons [Repealed effective July 1, 2029]

§ 9472. Pharmacy benefit managers; required practices with respect to health insurers and covered persons [Repealed effective July 1, 2029]

• (a) A pharmacy benefit manager that provides pharmacy benefit management for a health
  plan has a fiduciary duty to its health insurer client that includes a duty to be
  fair and truthful toward the health insurer, to act in the health insurer’s best interests,
  and to perform its duties with care, skill, prudence, and diligence. In the case of
  a health benefit plan offered by a health insurer as defined by subdivision 9471(2)(A) of this title, the health insurer shall remain responsible for administering the health benefit
  plan in accordance with the health insurance policy or subscriber contract or plan
  and in compliance with all applicable provisions of Title 8 and this title. (b) A pharmacy benefit manager shall provide notice to the health insurer that the terms
  contained in subsection (c) of this section may be included in the contract between
  the pharmacy benefit manager and the health insurer. (c) A pharmacy benefit manager that provides pharmacy benefit management for a health
  plan shall do all of the following: (1) Provide all financial and utilization information requested by a health insurer relating
  to the provision of benefits to beneficiaries through that health insurer’s health
  plan and all financial and utilization information relating to services to that health
  insurer. A pharmacy benefit manager providing information under this subsection may
  designate that material as confidential. Information designated as confidential by
  a pharmacy benefit manager and provided to a health insurer under this subsection
  shall not be disclosed by the health insurer to any person without the consent of
  the pharmacy benefit manager, except that disclosure may be made by the health insurer: (A) in a court filing under the consumer protection provisions of 9 V.S.A. chapter 63, provided that the information shall be filed under seal and that prior to the information
  being unsealed, the court shall give notice and an opportunity to be heard to the
  pharmacy benefit manager on why the information should remain confidential; (B) to State and federal government officials; (C) when authorized by 9 V.S.A. chapter 63; (D) when ordered by a court for good cause shown; or (E) when ordered by the Commissioner as to a health insurer as defined in subdivision 9471(2)(A) of this title pursuant to the provisions of Title 8 and this title. (2) Notify a health insurer in writing of any proposed or ongoing activity, policy, or
  practice of the pharmacy benefit manager that presents, directly or indirectly, any
  conflict of interest with the requirements of this section. (3) With regard to the dispensation of a substitute prescription drug for a prescribed
  drug to a beneficiary in which the substitute drug costs more than the prescribed
  drug and the pharmacy benefit manager receives a benefit or payment directly or indirectly,
  disclose to the health insurer the cost of both drugs and the benefit or payment directly
  or indirectly accruing to the pharmacy benefit manager as a result of the substitution. (4) If the pharmacy benefit manager derives any payment or benefit for the dispensation
  of prescription drugs within the State based on volume of sales for certain prescription
  drugs or classes or brands of drugs within the State, pass that payment or benefit
  on in full to the health insurer. (5) Disclose to the health insurer all financial terms and arrangements for remuneration
  of any kind that apply between the pharmacy benefit manager and any prescription drug
  manufacturer that relate to benefits provided to beneficiaries under or services to
  the health insurer’s health plan, including formulary management and drug-switch programs,
  educational support, claims processing, and pharmacy network fees charged from retail
  pharmacies and data sales fees. A pharmacy benefit manager providing information under
  this subsection may designate that material as confidential. Information designated
  as confidential by a pharmacy benefit manager and provided to a health insurer under
  this subsection shall not be disclosed by the health insurer to any person without
  the consent of the pharmacy benefit manager, except that disclosure may be made by
  the health insurer: (A) in a court filing under the consumer protection provisions of 9 V.S.A. chapter 63, provided that the information shall be filed under seal and that prior to the information
  being unsealed, the court shall give notice and an opportunity to be heard to the
  pharmacy benefit manager on why the information should remain confidential; (B) when authorized by 9 V.S.A. chapter 63; (C) when ordered by a court for good cause shown; or (D) when ordered by the Commissioner as to a health insurer as defined in subdivision 9471(2)(A) of this title pursuant to the provisions of Title 8 and this title. (d) At least annually, a pharmacy benefit manager that provides pharmacy benefit management
  for a health plan shall disclose to the health insurer, the Department of Financial
  Regulation, and the Green Mountain Care Board the aggregate amount the pharmacy benefit
  manager retained on all claims charged to the health insurer for prescriptions filled
  during the preceding calendar year in excess of the amount the pharmacy benefit manager
  reimbursed pharmacies. (e) A pharmacy benefit manager contract with a health insurer shall not contain any provision
  purporting to reserve discretion to the pharmacy benefit manager to move a drug to
  a higher tier or remove a drug from its drug formulary any more frequently than two
  times per year. (f)(1) A pharmacy benefit manager shall not require a covered person purchasing a covered
  prescription drug to pay an amount greater than the lesser of: (A) the cost-sharing amount under the terms of the health benefit plan; (B) the maximum allowable cost for the drug; or (C) the amount the covered person would pay for the drug if the covered person were paying
  the cash price. (2) Any amount paid by a covered person under subdivision (1) of this subsection shall
  be attributed toward any deductible and, to the extent consistent with Sec. 2707 of
  the Public Health Service Act (42 U.S.C. § 300gg-6), the annual out-of-pocket maximums under the covered person’s health benefit plan. (g) Compliance with the requirements of this section is required for pharmacy benefit
  managers entering into contracts with a health insurer in this State for pharmacy
  benefit management in this State. (Added 2007, No. 80, § 8; amended 2013, No. 144 (Adj. Sess.), § 12, eff. May 27, 2014; 2021, No. 131 (Adj. Sess.), § 2, eff. January 1, 2023; repealed by 2023, No. 127 (Adj. Sess.), § 4(a)(2), eff. July 1, 2029.) § 9472. Repealed. 2023, No. 127 (Adj. Sess.), § 4(a)(2), eff. July 1, 2029. (Added 2007, No. 80, § 8; amended 2013, No. 144 (Adj. Sess.), § 12, eff. May 27, 2014; 2021, No. 131 (Adj. Sess.), § 2, eff. January 1, 2023; repealed by 2023, No. 127 (Adj. Sess.), § 4(a)(2), eff. July 1, 2029.)